Stock Analysts

General Motors (GM) Divulges Investment Details in Brazil

General Motors Company GM has shared details of its investment in Brazil. Per a Reuters report, the company has invested $603 million (1.9 billion reais) in its Joinville factory in southern Brazil. The company also announced capital spending of 1.2 billion reais in its plant on the outskirts of Sao Paulo […]

Stock Analysts

General Dynamics’ (GD) Unit Wins $311M U.S. Army Contract

General Dynamics Corporation ’s GD business unit, Land Systems, secured a contract to design, develop and integrate several engineering changes into the Abrams M1A2 SEP V3 (System Enhancement Package Version 3). Contract Details Valued at $310.6 million, the contract has been awarded by the Army Contracting Command, Warren, MI. […]

Stock Analysts

Ride on Rising P/E Investing With 5 Top-Ranked Stocks

Generally, investors love stocks with a low price-to-earnings (P/E) ratio. The perception is that the lower the P/E, the higher will be the value of the stock. The simple logic that a stock’s current market price does not justify (is not equivalent to) its higher earnings and therefore has room to run is behind investors’ inclination toward low P/E stocks […]

Stock Analysts

AstraZeneca’s Faslodex Gets FDA Nod in First-Line Setting

AstraZeneca, plc AZN announced that Faslodex has received FDA approval for a label extension in the first-line monotherapy setting for the treatment of advanced breast cancer. Faslodex has been approved as a monotherapy treatment for previously untreated post-menopausal women with hormone-receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer. So far this year, AstraZeneca’s shares have moved up 7%, comparing unfavorably to a 10.8% increase for the industry . […]

Stock Analysts

Novo Nordisk’s Victoza Gets FDA Nod for Label Expansion

Novo Nordisk A/S’ NVO shares gained 1.1% on Friday after it announced that the FDA has approved the label expansion of Victoza. The drug is now approved as a treatment to reduce the risk of major adverse cardiovascular (CV) events including heart attack, stroke and CV death, in adults with type II diabetes and established CV disease. […]

Stock Analysts

6 Reasons That Make Chemours (CC) a Solid Choice Right Now

The Chemours Company ’s CC stock looks promising at the moment. The company has seen its shares shoot up around 116% year to date. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead […]

Momentum Stocks

Bear of the Day: Match Group (MTCH)

When you’re looking for ideas to invest in, it’s important to check out the earnings history of the stock you’re investigating. Not only what the growth has been in earnings but how has the sentiment of analysts changed over time? Historically, do analysts have high hopes then dial back their expectations […]

Momentum Stocks

Bull of the Day: Diageo (DEO)

There’s never a dull moment in the stock market. If you were getting used to sideways action, the events of the last couple of weeks have shown that you shouldn’t be complacent. We’ve had two spikes in volatility to go along with major market averages coming down to test 50-day and 200-day moving averages. […]

Mergers & Acquisitions

Polaris Announces Friendly Acquisition by Vulcan Materials Company

Polaris Announces Friendly Acquisition by Vulcan Materials Company PR Newswire VANCOUVER, Aug 28, 2017 VANCOUVER , Aug 28, 2017 /PRNewswire/ – Polaris Materials Corporation (TSX:PLS) (the “Company” or “Polaris”), today announced that it has entered into a definitive arrangement agreement (the “Arrangement Agreement”) with Vulcan Materials Company (NYSE:VMC) (“Vulcan”), pursuant to which Vulcan , through an indirect subsidiary, will acquire all of the issued and outstanding shares of Polaris for C$2.79 per share in cash by way of a statutory plan of arrangement (the “Arrangement”) under the Business Corporations Act ( British Columbia ). The price per share implies an aggregate fully diluted equity value for Polaris of approximately C$252 million . […]

Mergers & Acquisitions

Cognizant Completes TMG Health Acquisition, Solidifies Position as Top Service Provider for Government Managed Healthcare Programs in U.S.

Cognizant Completes TMG Health Acquisition, Solidifies Position as Top Service Provider for Government Managed Healthcare Programs in U.S. Cognizant Establishes National Center of Excellence for Medicare/Medicaid services at TMG Health Facility near Scranton, Pennsylvania Acquisition Expands Cognizant’s Business Process-as-a-Service Solutions for Government and Public Health Programs PR Newswire TEANECK, N.J., Aug. […]

Mergers & Acquisitions

CBS Corporation To Acquire Network Ten In Australia

CBS Corporation To Acquire Network Ten In Australia Deal to Buy Network Ten Will Accelerate CBS’ Global Growth Strategy in Key English-speaking Market Acquisition Also Paves the Way to Launch CBS All Access in Australia PR Newswire SYDNEY and AMSTERDAM and NEW YORK, Aug. 27, 2017 SYDNEY and AMSTERDAM and NEW YORK, Aug. […]

Stock Analysts

Will Endo (ENDP) Continue to Disappoint Investors in 2017?

We issued an updated report on Endo International plc ENDP on Aug 24. Endo, a global specialty pharmaceutical company focused on branded and generic pharmaceuticals, was formed following the acquisition of Paladin Labs. Revenues from the Generics base business is under significant pressure due to intensifying consortium pricing pressures and additional competitive entrants and product discontinuations as well as discrete factors, including destocking and shifts in purchase timing due to market conditions. […]